C12N 2502/1128
Erythrocytes
C12N2502/1128 (Erythrocytes) appears on 2 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 6
- Assignees
- 5
- Inventors
- 18
- Latest grant
- 4 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Beads for targted signla delivery31 Jul 2025US 2025/0242045 A1Rubhu Biologics, Inc.
- Genetically engineered erythrocytes carrying anti-pd-1 single chain antibody and preparation method therefor8 Feb 2024US 2024/0043802 A1
- Ordered processing of blood products to produce therapeutically active cells25 Aug 2022US 2022/0267726 A1GPB Scientific, LLC
- Process for generating genetically engineered autologous t cells21 Oct 2021US 2021/0324331 A1Amgen Inc.
- In vitro propagation of babesia microti22 Mar 2018US 2018/0080004 A1Fuller Laboratories
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.